Proton Partners International

Proton Partners International is a company based in Wales created by Neil Woodford and Professor Karol Sikora to develop Proton therapy facilities in the United Kingdom and elsewhere.

It is developing centres in Newport, Wales, Bomarsund, Northumberland, and Reading, Berkshire and has raised in excess of £63 million of equity including £10 million from the Welsh Life Sciences Fund[1] and companies associated with Woodford. It secured £30 million from Shawbrook Bank in January 2016.[2] The Northumberland site benefited from a grant of £450,000 from the Let’s Grow regional growth fund programme.[3]

Graham Construction is developing a cancer treatment centre in the Thames Valley Science Park in Reading for the company at a cost of £30 million. This is due for completion at the end of 2017.[4]

It bought the Gulf International Cancer Centre in Abu Dhabi in November 2016 as part of plans to create the first proton beam therapy treatment centre in the United Arab Emirates.[5]

Equipment and services are to be provided by Ion Beam Applications. [6] [7]


References

  1. ↑ "Construction begins on UK's first proton beam therapy cancer treatment centre". Wales on line. 18 January 2016. Retrieved 24 December 2016.
  2. ↑ "Neil Woodford-backed Proton Partners International receives £30m loan from Shawbrook bank to fund development of three proton therapy centres". City AM. 6 January 2016. Retrieved 24 December 2016.
  3. ↑ "Cancer treatment centre in Northumberland backed with grant from Journal's Let's Grow fund". Chronicle Live. 18 July 2016. Retrieved 24 December 2016.
  4. ↑ "GRAHAM Construction starts work on £30m cancer centre in Reading". Builder and Engineer. 16 December 2016. Retrieved 24 December 2016.
  5. ↑ "PROTON THERAPY CENTRE FOR ABU DHABI". International medical Travel Journal. 25 November 2016. Retrieved 24 December 2016.
  6. ↑ "BRIEF-Ion Beam Applications signs two contracts with Proton Partners International". Reuters. 13 December 2016. Retrieved 24 December 2016.
  7. ↑ "Proton Partners acquires Blue Phantom2 data acquisition system to support innovative cancer treatment". News medical. 9 December 2016. Retrieved 24 December 2016.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.